These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8919637

  • 1. The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
    Miners JO, Birkett DJ.
    Gen Pharmacol; 1996 Mar; 27(2):245-9. PubMed ID: 8919637
    [Abstract] [Full Text] [Related]

  • 2. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.
    Rasmussen BB, Brøsen K.
    Ther Drug Monit; 1996 Jun; 18(3):254-62. PubMed ID: 8738764
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.
    Nyéki A, Biollaz J, Kesselring UW, Décosterd LA.
    J Chromatogr B Biomed Sci Appl; 2001 May 05; 755(1-2):73-84. PubMed ID: 11393735
    [Abstract] [Full Text] [Related]

  • 7. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities.
    Relling MV, Lin JS, Ayers GD, Evans WE.
    Clin Pharmacol Ther; 1992 Dec 05; 52(6):643-58. PubMed ID: 1458773
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.
    Krul C, Hageman G.
    J Chromatogr B Biomed Sci Appl; 1998 May 08; 709(1):27-34. PubMed ID: 9653923
    [Abstract] [Full Text] [Related]

  • 10. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
    Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini EK.
    Biomed Chromatogr; 2007 Feb 08; 21(2):190-200. PubMed ID: 17221922
    [Abstract] [Full Text] [Related]

  • 11. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
    Lelo A, Kjellen G, Birkett DJ, Miners JO.
    J Pharmacol Exp Ther; 1989 Jan 08; 248(1):315-9. PubMed ID: 2913277
    [Abstract] [Full Text] [Related]

  • 12. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.
    Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF.
    Pharmacogenetics; 1992 Jun 08; 2(3):116-27. PubMed ID: 1306111
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
    Chen Y, Xiao P, Ou-Yang DS, Fan L, Guo D, Wang YN, Han Y, Tu JH, Zhou G, Huang YF, Zhou HH.
    Clin Exp Pharmacol Physiol; 2009 Aug 08; 36(8):828-33. PubMed ID: 19215233
    [Abstract] [Full Text] [Related]

  • 14. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females.
    Wenk M, Todesco L, Krähenbühl S.
    Br J Clin Pharmacol; 2004 Apr 08; 57(4):495-9. PubMed ID: 15025748
    [Abstract] [Full Text] [Related]

  • 15. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.
    Tsutsumi K, Kotegawa T, Matsuki S, Tanaka Y, Ishii Y, Kodama Y, Kuranari M, Miyakawa I, Nakano S.
    Clin Pharmacol Ther; 2001 Aug 08; 70(2):121-5. PubMed ID: 11503005
    [Abstract] [Full Text] [Related]

  • 16. Salivary clearance and urinary metabolic pattern of caffeine in healthy children and in pediatric patients with hepatocellular diseases.
    el-Yazigi A, Shabib S, al-Rawithi S, Yusuf A, Legayada ES, al-Humidan A.
    J Clin Pharmacol; 1999 Apr 08; 39(4):366-72. PubMed ID: 10197295
    [Abstract] [Full Text] [Related]

  • 17. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine.
    Vistisen K, Poulsen HE, Loft S.
    Carcinogenesis; 1992 Sep 08; 13(9):1561-8. PubMed ID: 1394840
    [Abstract] [Full Text] [Related]

  • 18. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH, Nierenberg DW, Bresnick E.
    Cancer Epidemiol Biomarkers Prev; 1995 Mar 08; 4(2):139-46. PubMed ID: 7742721
    [Abstract] [Full Text] [Related]

  • 19. Effects of peppermint tea consumption on the activities of CYP1A2, CYP2A6, Xanthine Oxidase, N-acetyltranferase-2 and UDP-glucuronosyltransferases-1A1/1A6 in healthy volunteers.
    Begas E, Tsioutsiouliti A, Kouvaras E, Haroutounian SA, Kasiotis KM, Kouretas D, Asprodini E.
    Food Chem Toxicol; 2017 Feb 08; 100():80-89. PubMed ID: 28011360
    [Abstract] [Full Text] [Related]

  • 20. Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?
    Jetter A, Kinzig M, Rodamer M, Tomalik-Scharte D, Sörgel F, Fuhr U.
    Eur J Clin Pharmacol; 2009 Apr 08; 65(4):411-7. PubMed ID: 19082994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.